0001209191-19-039017.txt : 20190625 0001209191-19-039017.hdr.sgml : 20190625 20190625185832 ACCESSION NUMBER: 0001209191-19-039017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190625 FILED AS OF DATE: 20190625 DATE AS OF CHANGE: 20190625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDWARDS MARK G CENTRAL INDEX KEY: 0001190429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 19919655 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-25 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001190429 EDWARDS MARK G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 0 0 0 Common Stock 2019-06-25 4 A 0 3750 0.00 A 203750 D Stock Option (Right to Buy) 2.19 2019-06-25 4 A 0 7500 0.00 A 2019-07-25 2029-06-25 Common Stock 7500 7500 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest in two equal consecutive annual installments on June 25, 2020 and June 25, 2021, subject to Reporting Person's continuous service to the Company. The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Reporting Person's continuous service to the Company. /s/ Martha Adler, Attorney-In-Fact 2019-06-25